Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-04-22 Tax Withholding | 2026-04-24 9:30 pm | N/A N/A | MANNKIND CORP | MNKD | Prentiss Christopher B Chief Financial Officer | 12,267 | $2.74 | 338,924 (Direct) | View |
| 2026-03-23 Option Award | 2026-03-25 9:30 pm | N/A N/A | MANNKIND CORP | MNKD | Prentiss Christopher B Chief Financial Officer | 438,000 | $0 | 438,000 (Direct) | View |
| 2026-03-01 Option Award | 2026-03-03 9:50 pm | N/A N/A | MANNKIND CORP | MNKD | Prentiss Christopher B Chief Financial Officer | 5,000 | $3.27 | 348,854 (Direct) | View |
| 2025-07-15 Tax Withholding | 2025-07-17 8:45 pm | N/A N/A | MANNKIND CORP | MNKD | Prentiss Christopher B Chief Financial Officer | 11,540 | $3.85 | 343,854 (Direct) | View |
| 2025-05-13 Option Award | 2025-05-15 8:34 pm | N/A N/A | MANNKIND CORP | MNKD | Prentiss Christopher B Chief Financial Officer | 264,000 | $0 | 498,193 (Direct) | View |
| 2024-05-15 Option Award(A) | 2025-03-28 8:20 pm | N/A N/A | MANNKIND CORP | MNKD | Prentiss Christopher B Chief Financial Officer | 103,600 | $0 | 103,600 (Direct) | View |
| 2024-05-15 Option Award | 2024-05-17 9:00 pm | N/A N/A | MANNKIND CORP | MNKD | Prentiss Christopher B Chief Financial Officer | 390,600 | $0 | 390,600 (Direct) | View |
| 2021-11-24 Option Award | 2021-11-24 4:10 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer | 18,750 | $0 | 0 (Direct) | View |
| 2021-11-24 Equity Swap | 2021-11-24 4:10 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer | 163,767 | $0 | 0 (Direct) | View |